Skip to main content

With 8.3% CAGR, Flow Cytometry Market Size to Hit USD 9.22 Billion by 2029

According to Fortune Business Insights, The global flow cytometry market size was valued at USD 4.89 billion in 2021. The market is set to expand from USD 5.27 billion in 2022 to USD 9.22 billion by 2029, exhibiting a CAGR of 8.3% over the forecast period. Market Value to Rise Due to Growing Awareness Regarding Chronic Diseases

Pune, India, March 30, 2023 (GLOBE NEWSWIRE) — The global flow cytometry market size was valued at USD 4.89 billion in 2021. The market is set to expand from USD 5.27 billion in 2022 to USD 9.22 billion by 2029, exhibiting a CAGR of 8.3% over the forecast period. The rise is being driven by surging initiatives in the field of immuno-oncology and immunology research and the soaring adoption of advanced research techniques.

This information is provided by Fortune Business Insights™ in its research report, titled “Flow Cytometry Market, 2022-2029”.


Get Sample PDF Brochure:  

https://www.fortunebusinessinsights.com/enquiry/sample/flow-cytometry-market-107325


Key Industry Development:

November 2022 – Sony Corporation rolled out a flow cytometry data analysis cloud solution dubbed SFA – Life Sciences Cloud Platform. The platform assists in identifying rare cells such as cancer and stem cells from numerous cell populations using flow cytometers data.

Drivers and Restraints:

Market Value to Rise Due to Growing Awareness Regarding Chronic Diseases

One of the major factors propelling the flow cytometry market growth is the increasing prevalence of chronic diseases such as cancer, HIV/AIDS, and leukemia. This has escalated the demand for awareness regarding advanced technologies for disease diagnosis and conducting research associated with chronic diseases.

However, the market growth could be hindered due to the high cost associated with various instruments.

COVID-19 Impact:

Increase in Industry Revenue Due to Escalated Product Demand for Diagnostic Purposes

The COVID-19 pandemic led to an increase in flow cytometry demand in 2020. This can be attributed to the need for diagnosing the clinical progression of coronavirus. The pandemic period also registered a rise in adoption of reagents and instruments. The augmented product adoption helped researchers to assess the effect of COVID-19-specific immune response on the human body.

Segments:

Instrument Segment to Record Appreciable Growth Due to Soaring Adoption of Cell Sorters

Based on product & service, the market is segmented into software & services, consumables & reagents, and instruments. The instruments segment is estimated to expand at a moderate CAGR over the forecast period. This is on account of increasing technological advancements in cell sorting instruments and analyzers.

Bead Based Segment to Register Commendable Growth Owing to Introduction of Advanced Products

On the basis of technology, the market is fragmented into bead based and cell based. The cell based segment is expected to grow at a considerable CAGR throughout the estimated period. The rise is driven by numerous factors such as the escalated prevalence of chronic diseases and increasing patient visits to clinics and hospitals.

To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit:

https://www.fortunebusinessinsights.com/flow-cytometry-market-107325


Research Segment to Gain Traction on Account of Growing Investments

Based on application, the market is subdivided into research and clinical. The research segment is projected to record a healthy CAGR over the study period. The surge is being driven by increasing investments in the biotechnology, life science, and biopharmaceutical research industries.

On the basis of region, the market for flow cytometry is segmented into North America, Asia Pacific, Europe, and the rest of the world.

Report Coverage:

The report provides an in-depth analysis of the major aspects propelling industry expansion over the forecast period. It further gives an insight into the significant factors impelling market growth throughout the estimated period. Additional aspects of the report include the key steps taken by leading market participants for strengthening their business prospects.

Quick Buy – Flow Cytometry Market Research Report:

https://www.fortunebusinessinsights.com/checkout-page/107325


Regional Insights:

North America to Record Appreciable CAGR Owing to Rapid Introduction of Software & Services

The North America flow cytometry market share is slated to register considerable growth over the forecast period. The rise can be attributed to the surging adoption of clinical flow cytometers and the introduction of software and services.

Europe is set to grow at a considerable CAGR throughout the estimated period. The surge is driven by the growing prevalence of chronic diseases and the rising research demand for disease treatment.

Competitive Landscape:

Leading Players Introduce Products to Secure Competitive Edge

Prominent flow cytometry companies are focused on the development and launch of new products for maintaining their position in the market. Some of the other steps include acquisitions, mergers, collaborations, and the formation of alliances. Other steps comprise an increase in research activities.

List of Key Players Mentioned in the Report:

  • Miltenyi Biotec (U.S.)
  • BD (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Danaher (U.S.)
  • Thermo Fisher Scientific (U.S.)
  • Agilent Technologies, Inc. (U.K.)
  • DiaSorin S.p.A. (Italy)
  • Sysmex (Japan)
  • Apogee Flow Systems Ltd. (U.K.)
  • Sony Biotechnology Inc (U.S.)

Speak To Our Analyst: 

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/flow-cytometry-market-107325


Table Of Content :

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
    • Market Trends
  • Key Insights
    • Prevalence of HIV and Cancer, By Key Countries
    • Technological Advancements in Flow Cytometry
    • Key Industry Developments -Mergers, Partnerships, & Acquisitions
    • Impact of COVID-19 on Global Flow Cytometry Market
  • Global Flow Cytometry Market Analysis, Insights and Forecast, 2018-2029
    • Market Analysis, Insights and Forecast – By Products & Services
      • Instruments
        • Analyzer
        • Sorter
      • Reagents & Consumables
      • Software & Services
    • Market Analysis, Insights and Forecast – By Technology
      • Cell Based
      • Bead Based
    • Market Analysis, Insights and Forecast – By Application
      • Clinical
      • Research
    • Market Analysis, Insights and Forecast – By End-user
      • Pharmaceuticals & Biotechnology Industries
      • Academic & Research Organizations
      • Hospitals & Diagnostics
      • Others
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Rest of the World
  • North America Flow Cytometry Market Analysis, Insights and Forecast, 2018-2029
    • Market Analysis, Insights and Forecast – By Products & Services
      • Instruments
        • Analyzer
        • Sorter
      • Reagents & Consumables
      • Software & Services
    • Market Analysis, Insights and Forecast – By Technology
      • Cell Based
      • Bead Based
    • Market Analysis, Insights and Forecast – By Application
      • Clinical
      • Research
    • Market Analysis, Insights and Forecast – By End-user
      • Pharmaceuticals & Biotechnology Industries
      • Academic & Research Organizations
      • Hospitals & Diagnostics
      • Others
    • Market Analysis, Insights and Forecast – By Country
      • U.S.
        • By Application
      • Canada
        • By Application
  • Europe Flow Cytometry Market Analysis, Insights and Forecast, 2018-2029
    • Market Analysis, Insights and Forecast – By Products & Services
      • Instruments
        • Analyzer
        • Sorter
      • Reagents & Consumables
      • Software & Services
    • Market Analysis, Insights and Forecast – By Technology
      • Cell Based
      • Bead Based
    • Market Analysis, Insights and Forecast – By Application
      • Clinical
      • Research
    • Market Analysis, Insights and Forecast – By End-user
      • Pharmaceuticals & Biotechnology Industries
      • Academic & Research Organizations
      • Hospitals & Diagnostics
      • Others
    • Market Analysis, Insights and Forecast – By Country/ Sub-region
      • U.K.
        • By Application
      • Germany
        • By Application
      • France
        • By Application
      • Italy
        • By Application
      • Spain
        • By Application
      • Scandinavia
        • By Application
      • Rest of Europe
        • By Application

Toc Continue…


Ask for Customization of this Report:

https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/flow-cytometry-market-107325


Frequently Ask Question :

What is the future of flow cytometry?

  • The increasing introduction of technologically advanced flow cytometer and consumables, the rising awareness of chronic disease, growing research institutes and their activities, and increasing funding initiatives for research are expected to drive market growth.

Who is the manufacturer of flow cytometry?

  • Miltenyi Biotec (U.S.), BD (U.S.) , Bio-Rad Laboratories, Inc. (U.S.) , Danaher (U.S.) , Thermo Fisher Scientific (U.S.) , Agilent Technologies, Inc. (U.K.) , DiaSorin S.p.A. (Italy) , Sysmex (Japan) , Apogee Flow Systems Ltd. (U.K.) , Sony Biotechnology Inc (U.S.)

Discover more research Reports on Healthcare Industry, by Fortune Business Insights :

ePharmacy Market Size, Share & Growth Analysis

Spinal Muscular Atrophy Treatment Market Size, Growth Report, 2026

Anti-Inflammatory Drugs Market Size, Share, Growth Report, 2027

Ophthalmic Lasers Market Size, Share, Growth, Trends 2026

Continuous Renal Replacement Therapy (CRRT) Market Size, Growth Report, 2027

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.